If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...

The UK becomes the latest country in President Donald Trump’s long line of trade agreements, though it is the first region to ...

Lupin has FDA approval for Armlupeg 6mg/0.6ml injection in a single-dose prefilled syringe, for subcutaneous use, as a ...

Eisai has submitted a new drug application to Japan’s PMDA seeking approval for Leqembi’s SC formulation, SC-AI, for early ...

West Pharmaceutical Services is the winner of the Product Launches Award for Prefillable Syringe Systems in the 2025 ...

PrEP has become an important tool in preventing HIV infection, helping reduce the risk of contracting the virus by up to 99%; however, its use has been disrupted this year. The AIDS Vaccine Advocacy ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

Gilead now own the rights to Sprint's preclinical oncology immunotherapy programme, which targets the novel cancer target, ...

The US Food and Drug Administration (FDA) has accepted the new drug application (NDA) for BeOne Medicines’ B-cell lymphoma 2 ...

While the Phase III results confirm prior analyst sentiments, a KOL notes that GLP-1RAs could still show potential in the ...

Not long after cutting its sales forecast for 2025, Valneva has decided to decrease its operational footprint in France by ...

Lilly breaking through the $1tn market cap ceiling comes as investors have increasingly turned to pharma stocks. The S&P 500 ...